Email this article Meet the Editorial Board Member
- Authors: Beretta G.1
-
Affiliations:
- Department of Experimental Oncology and Molecular Medicine,, Fondazione IRCCS Istituto Nazionale dei Tumori,
- Issue: Vol 31, No 13 (2024)
- Pages: 1607-1607
- Section: Anti-Infectives and Infectious Diseases
- URL: https://rjpbr.com/0929-8673/article/view/644269
- DOI: https://doi.org/10.2174/092986733113240109003330
- ID: 644269
Cite item
Full Text
About the authors
Giovanni Beretta
Department of Experimental Oncology and Molecular Medicine,, Fondazione IRCCS Istituto Nazionale dei Tumori,
Email: info@benthamscience.net
References
- Beretta, G.L.; Binaschi, M.; Zagni, E.; Capuani, L.; Capranico, G. Tethering a type IB topoisomerase to a DNA site by enzyme fusion to a heterologous site-selective DNA-binding protein domain. Cancer Res., 1999, 59(15), 3689-3697.
- Beretta, G.L.; Benedetti, V.; Cossa, G.; Assaraf, Y.G.A.; Bram, E.; Gatti, L.; Corna, E.; Carenini, N.; Colangelo, D.; Howell, S.B.; Zunino, F.; Perego, P. Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. Biochem. Pharmacol., 2010, 79(8), 1108-1117. doi: 10.1016/j.bcp.2009.12.002
- Perego, P.; Gatti, L.; Beretta, G.L. The ABC of glycosylation. Nat. Rev. Cancer, 2010, 10(7), 523. doi: 10.1038/nrc2789-c1
- Perego, P.; Cossa, G.; Tinelli, S.; Corna, E.; Carenini, N.; Gatti, L.; De Cesare, M.; Ciusani, E.; Zunino, F.; Luison, E.; Canevari, S.; Zaffaroni, N.; Beretta, G.L. Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition. Biochem. Pharmacol., 2012, 83(1), 27-36. doi: 10.1016/j.bcp.2011.09.021
- Beretta, G.L.; Folini, M.; Cavalieri, F.; Yan, Y.; Fresch, E.; Kaliappan, S.; Hasenöhrl, C.; Richardson, J.J.; Tinelli, S.; Fery, A.; Caruso, F.; Zaffaroni, N. Unravelling "off-target" effects of redox-active polymers and polymer multilayered capsules in prostate cancer cells. Nanoscale, 2015, 7(14), 6261-6270. doi: 10.1039/c4nr07240e
- Cavalieri, F.; Beretta, G.L.; Cui, J.; Braunger, J.A.; Yan, Y.; Richardson, J.J.; Tinelli, S.; Folini, M.; Zaffaroni, N.; Caruso, F. Redox-sensitive PEG-polypeptide nanoporous particles for survivin silencing in prostate cancer cells. Biomacromolecules, 2015, 16(7), 2168-2178. doi: 10.1021/acs.biomac.5b00562
- Zaffaroni, N.; Beretta, G.L. Resveratrol and prostate cancer: the power of phytochemicals. Curr. Med. Chem., 2021, 28(24), 4845-4862. doi: 10.2174/0929867328666201228124038
- Stamatakos, S.; Beretta, G.L.; Vergani, E.; Dugo, M.; Corno, C.; Corna, E.; Tinelli, S.; Frigerio, S.; Ciusani, E.; Rodolfo, M.; Perego, P.; Gatti, L. Deregulated FASN expression in BRAF inhibitor resistant melanoma cells unveils new targets for drug combinations. Cancers (Basel), 2021, 13(9), 2284. doi: 10.3390/cancers13092284
- Vergani, E.; Beretta, G.L.; Aloisi, M.; Costantino, M.; Corno, C.; Frigerio, S.; Tinelli, S.; Dugo, M.; Accattatis, F.M.; Granata, A.; Arnaboldi, L.; Rodolfo, M.; Perego, P.; Gatti, L. Targeting of the lipid metabolism impairs resistance to BRAF kinase inhibitor in melanoma. Front. Cell Dev. Biol., 2022, 10, 927118. doi: 10.3389/fcell.2022.927118
- Bhangu, S.K.; Fernandes, S.; Beretta, G.L.; Tinelli, S.; Cassani, M.; Radziwon, A.; Wojnilowicz, M.; Sarpaki, S.; Pilatis, I.; Zaffaroni, N.; Forte, G.; Caruso, F.; Ashokkumar, M.; Cavalieri, F. Transforming the chemical structure and bio-nano activity of doxorubicin by ultrasound for selective killing of cancer cells. Adv. Mater., 2022, 34(13), e2107964. doi: 10.1002/adma.202107964
Supplementary files
